editorial . 2014 Jul 4;1(7):484–485. doi: 10.18632/oncoscience.63
© 2014 Martineau et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Figure 1. 4E-BP mimics as an alternative to mTOR inhibitors.
